首次冻胚移植后生化或临床妊娠丢失不影响后续移植结局
该回顾性队列研究纳入2017年1月至2021年12月间在大学附属生殖中心连续两次单胚胎冻胚移植(FET)的患者,比较首次FET后发生生化或临床妊娠丢失者与首次移植失败者在第二次FET中的妊娠丢失率。在2103例连续两次整倍体FET患者中,首次生化丢失后第二次生化丢失率为9.9%、临床丢失率为10.5%,与既往移植失败者(9.6%,P=0.890;10.9%,P=0.556)无显著差异;首次临床丢失者第二次生化及临床丢失率亦与移植失败者相当(11.5% vs 9.6%,P=0.272;12.5% vs 10.9%,P=0.456)。在282例未检测胚胎FET中结果一致。结论认为整倍体或未检测FET后生化或临床妊娠丢失不增加后续移植妊娠丢失风险。
要点
- 首次整倍体FET后生化丢失者第二次生化丢失率9.9%,与移植失败者9.6%无显著差异(P=0.890)。
- 首次整倍体FET后临床丢失者第二次临床丢失率12.5%,与移植失败者10.9%无显著差异(P=0.456)。
- 未检测胚胎FET中既往妊娠丢失与移植失败者的后续丢失率亦无显著差异。
核心结论
- 整倍体或未检测FET后发生生化或临床妊娠丢失,不增加后续冻胚移植的妊娠丢失风险。
研究设计与样本
- 回顾性队列研究,纳入2017年1月至2021年12月在大学附属生殖中心连续两次单胚胎冻胚移植的患者。
- 比较首次FET后生化或临床妊娠丢失者与首次FET移植失败者在第二次FET中的妊娠丢失率。
- 整倍体FET分析人群2103例,未检测胚胎FET分析人群282例。
主要发现
- 首次整倍体FET生化丢失后,第二次FET生化丢失率9.9%、临床丢失率10.5%。
- 既往移植失败者第二次FET生化丢失率9.6%(P=0.890)、临床丢失率10.9%(P=0.556)。
- 首次整倍体FET临床丢失后,第二次FET生化丢失率11.5% vs 移植失败者9.6%(P=0.272),临床丢失率12.5% vs 10.9%(P=0.456)。
- 未检测胚胎FET(n=282)中,既往妊娠丢失与移植失败者的后续妊娠丢失率无显著差异。
临床怎么用
- 对于首次FET后发生生化或临床妊娠丢失的患者,后续移植决策可不必因既往妊娠丢失而过度担忧妊娠丢失风险增加。
局限性
- 回顾性研究设计,可能存在选择偏倚和混杂因素。
- 未检测胚胎分析样本量较小(n=282),结果解释需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does biochemical or clinical pregnancy loss after frozen embryo transfer (FET) increase the odds of pregnancy loss in a subsequent transfer? DESIGN: Retrospective cohort study evaluating patients who underwent two consecutive single FETs using either euploid or untested embryos at a university-affiliated fertility centre between January 2017 and December 2021. Patients who had experienced a biochemical or clinical pregnancy loss after the first FET were compared with those who had experienced implantation failure in the subsequent FET. RESULTS: Among 2103 patients who underwent two consecutive euploid FETs, those who had experienced a biochemical loss after their first euploid FET had a subsequent biochemical loss rate of 9.9% and a clinical loss rate of 10.5% in their second euploid FET. These rates did not significantly differ from those who had experienced previous implantation failure (9.6%, P = 0.890; 10.9%, P = 0.556, respectively). Similarly, among patients who had experienced a clinical loss in their first euploid FET, rates of biochemical and clinical loss in the second euploid transfer were comparable to those who had experienced previous implantation failure (11.5% versus 9.6%, P = 0.272; and 12.5% versus 10.9%, P = 0.456, respectively). These findings remained consistent when analysing untested (n = 282) FETs, with no significant differences in subsequent pregnancy loss rates between patients who had experienced previous pregnancy loss and those who had experienced implantation failure. CONCLUSIONS: Biochemical or clinical pregnancy loss after a euploid or untested FET is not associated with an increased risk of pregnancy loss in the subsequent transfer.
引用
- Barrett F, Kalafat E, Vessa B, et al. Biochemical or clinical pregnancy loss after first embryo transfer does not affect subsequent transfer outcome. Reprod Biomed Online. 2025. PMID: 41819682. doi:10.1016/j.rbmo.2025.105435
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。